Literature DB >> 30021119

Intralymphatic allergen immunotherapy against pollen allergy: A 3-year open follow-up study of 10 patients.

Lars Ahlbeck1, Emelie Ahlberg2, Ulla Nyström3, Janne Björkander4, Maria C Jenmalm2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 30021119     DOI： 10.1016/j.anai.2018.07.010

Source DB:  PubMed          Journal:  Ann Allergy Asthma Immunol        ISSN： 1081-1206            Impact factor:   6.347


× No keyword cloud information.
  5 in total

Review 1.  Efficacy and safety of intralymphatic immunotherapy in allergic rhinitis: A systematic review and meta-analysis.

Authors:  Nor Rahimah Aini; Norhayati Mohd Noor; Mohd Khairi Md Daud; Sarah K Wise; Baharudin Abdullah
Journal:  Clin Transl Allergy       Date:  2021-08-17       Impact factor: 5.871

2.  Intralymphatic immunotherapy with tyrosine-adsorbed allergens: a double-blind, placebo-controlled trial.

Authors:  Hye Jung Park; Sae-Hoon Kim; Yoo Seob Shin; Chul Hwan Park; Eun-Suk Cho; Seung Joon Choi; So Hyun Park; Joo Hyun Jung; Il Gyu Kang; Myoung Seok Lee; Dae Woo Kim; Sang Min Lee; Min-Suk Yang; Sang Pyo Lee
Journal:  Respir Res       Date:  2021-06-04

3.  A preseason booster prolongs the increase of allergen specific IgG4 levels, after basic allergen intralymphatic immunotherapy, against grass pollen seasonal allergy.

Authors:  Dan Weinfeld; Ulla Westin; Laila Hellkvist; Ulf-Henrik Mellqvist; Ingvar Jacobsson; Lars-Olaf Cardell
Journal:  Allergy Asthma Clin Immunol       Date:  2020-04-28       Impact factor: 3.406

Review 4.  Recent Advances in Allergen-Specific Immunotherapy in Humans: A Systematic Review.

Authors:  Sang Pyo Lee; Yoo Seob Shin; Sung-Yoon Kang; Tae-Bum Kim; Sang Min Lee
Journal:  Immune Netw       Date:  2022-02-07       Impact factor: 5.851

5.  Intralymphatic immunotherapy with one or two allergens renders similar clinical response in patients with allergic rhinitis due to birch and grass pollen.

Authors:  Lars Ahlbeck; Emelie Ahlberg; Janne Björkander; Caroline Aldén; Georgia Papapavlou; Laura Palmberg; Ulla Nyström; Pavlos Retsas; Patrik Nordenfelt; Totte Togö; Pål Johansen; Bo Rolander; Karel Duchén; Maria C Jenmalm
Journal:  Clin Exp Allergy       Date:  2022-04-01       Impact factor: 5.401
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.